Found 463 results in Expert Content

Summary: Experts provide an overview of why the properties and structure of pectin are well suited for site-specific delivery to the colon.

Summary: In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.

Intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.

Summary: Download this executive summary to learn more about safe and successful HPAPI product development and manufacturing using micronization.

Summary: As drug developers look to address unmet medical needs for orphan diseases, working with experienced partners can help in navigating key challenges such as a limited active pharmaceutical ingredient supply, efficient small-scale manufacturing for small patient populations and distribution logistics

Summary: To rapidly screen macromolecules’ potential for oral delivery, it is critical to assess multiple enabling technologies in parallel, targeting different biological barriers.

Summary: Decisions made throughout early and mid-stage clinical trials impact late-stage results and sometimes, entire programs and companies. Since some obstacles can prove overwhelming for startups, there is a lot to learn from those who successfully walked the path.

Read this case study to learn about how Catalent deployed its integrated OneXpress® Solution to expedite the transfer of a partner program to one of its late-stage manufacturing sites while optimizing the utilization of a limited supply of API.

Summary: During Fierce JPM Week 2022, Catalent’s President and COO Alessandro Maselli sat down and discussed how the pandemic changed the pharmaceutical landscape and how CDMOs...

Summary: In this webinar, experts provide an overview of the needs of different patient populations and examine the common challenges leading to non-compliance.